A randomised controlled trial of laparoscopic surgery for colorectal cancer

ISRCTN ISRCTN74883561
DOI https://doi.org/10.1186/ISRCTN74883561
ClinicalTrials.gov (NCT) NCT00003354
Protocol serial number G9328312
Sponsor Medical Research Council (MRC) (UK)
Funder Medical Research Council (MRC) (UK)
Submission date
06/04/2000
Registration date
06/04/2000
Last edited
28/10/2021
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr PJ Guillou
Scientific

Academic Unit of Surgery
Clinical Sciences Building
St James's University Hospital
Leeds
LS9 7TF
United Kingdom

Email not@provided.com

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Scientific titleA randomised controlled trial of laparoscopic surgery for colorectal cancer
Study acronymCLASICC
Study objectivesTo determine whether disease-free and overall survival from laparoscopic surgery for colorectal cancer is comparable to that of conventional surgery as assessed by conventional end-points of survival and surrogate end-points of pathological findings
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedColorectal cancer
InterventionLaparoscopic surgery vs conventional surgery
Intervention typeOther
Primary outcome measure(s)

1. Pathological endpoints (circumferential, longitudinal and high-tie mesenteric resection margins)
2. 30-day operative mortality
3. Disease-free survival, overall survival and local recurrence rates at 3 years
4. Local and distal recurrence rates, quality of life and cost effectiveness

Key secondary outcome measure(s)

1. Disease-free and overall survival at 5 years
2. Port-site and wound-site recurrence
3. Complication rates
4. Quality of life and cost effectiveness
5. Blood transfusion requirements
6. Loco-regional, anastomotic and distant metastases

Completion date31/12/2009

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexNot Specified
Target sample size at registration1000
Key inclusion criteria1. Clinical diagnosis of colorectal cancer (unless this occurs in the transverse colon)
2. Suitable for elective surgical resection by right hemicolectomy, left hemicolectomy, sigmoid colectomy, anterior resection or abdomino-perineal resection
3. Aged >18 years
4. Give written informed consent
Key exclusion criteria1. Adenocarcinoma of the transverse colon
2. Any contraindication to pneumoperitoneum
3. Acute intestinal obstruction
4. Malignancy within previous 5 years (except basal cell carcinoma, in situ carcinoma of cervix or prostate cancer)
5. Synchronous multiple adenocarcinomas
6. If female, be pregnant
7. Associated gastrointestinal disease that requires surgical intervention
Date of first enrolment01/07/1996
Date of final enrolment31/12/2009

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

Academic Unit of Surgery
Leeds
LS9 7TF
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing planNot provided at time of registration

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article 3 year results 20/07/2007 Yes No
Results article results 01/01/2010 Yes No
Results article results 01/11/2010 Yes No
Plain English results 28/10/2021 No Yes

Editorial Notes

28/10/2021: Cancer Research UK plain English results link added.